.jpg?format=webp&width=780)
Immune checkpoint inhibitors (ICI) have improved cancer management, but not all patients respond to ICI. A recent study found that eosinophils play a crucial role in mediating the immunotherapy effect in breast cancer by stimulating CD8+ T-cell activation. Intratumoral eosinophil recruitment was directed by CD4+ T-cells, IL-5 and IL-33, providing the rationale for targeting eosinophils to enhance ICI response.
Like
Save
Share